Tapering Bupropion XR 300 mg
For patients taking bupropion XR 300 mg daily, reduce the dose to 150 mg once daily for at least 1–2 weeks before complete discontinuation. 1, 2
Recommended Taper Schedule
Step 1: Reduce to 150 mg once daily
- Decrease from 300 mg to 150 mg XR once daily in the morning 2
- Maintain this dose for a minimum of 1–2 weeks before stopping completely 1
- This gradual reduction minimizes withdrawal symptoms and relapse risk 1
Step 2: Monitor for withdrawal symptoms
- Watch for irritability, mood changes, and anxiety during the taper 1, 3
- Sleep disturbances are common withdrawal symptoms 1
- Fatigue may emerge as the dose is reduced 1
- Headache and generalized aches have been reported with abrupt discontinuation 3
Step 3: Adjust taper speed based on tolerance
- If moderate-to-severe withdrawal symptoms develop, pause the taper and maintain the current dose for 1–2 additional weeks before resuming 4
- Slowing the taper rate is appropriate when withdrawal symptoms emerge 1
- The taper speed should be individualized according to symptom tolerance 4
Critical Safety Considerations
Do not stop abruptly
- Abrupt discontinuation increases the risk of withdrawal symptoms including irritable mood, anxiety, sleeplessness, headache, and generalized aches 3
- Gradual dose reduction is recommended for all antidepressant discontinuation 3
Monitor for mood destabilization
- If depressive symptoms re-emerge during the taper, consider transitioning to an alternative antidepressant rather than completing abrupt discontinuation 4
- Weekly assessment for mood changes is warranted during any antidepressant taper 4
Special Populations
Patients with hepatic impairment
- In moderate-to-severe hepatic impairment, the maximum dose is already 150 mg every other day, so further tapering may require extending the interval between doses 2
Patients with renal impairment
- Consider a slower taper in patients with reduced kidney function (GFR <90 mL/min), as bupropion metabolites accumulate 4
Common Pitfalls to Avoid
- Stopping too quickly: The FDA label explicitly states to taper when discontinuing 300 mg daily 2
- Ignoring withdrawal symptoms: Patients should be educated about potential withdrawal effects before starting the taper 3
- Failing to monitor mood: Depression relapse can occur during discontinuation, requiring resumption of treatment or switch to another agent 4